Imagion Biosystems Ltd
Our Latest Articles on Imagion Biosystems Ltd
|Article||14-Aug-2019||One ASX Med-Tech is Set to Transform The $100+Billion Cancer Diagnostic Market|
One ASX Med-Tech is Set to Transform The $100+Billion Cancer Diagnostic Market
Aug 14, 2019
MagSense is a unique, non-invasive, patent protected technology that fits into myriad addressable cancer diagnostic markets collectively worth $166 billion dollars and growing at 7% annually.